Skip to main content
Clinical Trials/NCT03555721
NCT03555721TerminatedNot Applicable

CytID Analysis of Oral Lesions

The University of Texas Health Science Center, Houston1 site in 1 country18 target enrollmentStarted: May 30, 2018Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Terminated
Enrollment
18
Locations
1
Primary Endpoint
Number of participants for whom biopsy and CytID results both indicate presence of malignant or premalignant oral lesions

Study Overview

Brief Summary

The purpose of this study is to correlate the results from a standard of care biopsy with CytID™ and hpvID™ swab tests for potentially premalignant and malignant oral lesions. The biopsy is considered standard of care and will be performed regardless of the patient's enrollment in the study. The study-related data gathering will not influence the treatment decisions of the clinician.

Study Design

Study Type
Observational
Observational Model
Other
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to 80 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Receive care at the Avenue 360 Health and Wellness Clinic, a not for profit dental clinic in the Montrose area of Houston
  • Present with a potentially malignant oral lesion (PMOL) for whom a biopsy is deemed necessary

Exclusion Criteria

  • Do not receive care at the Avenue 360 Health and Wellness Clinic, a not for profit dental clinic in the Montrose area of Houston
  • Do not present with a potentially malignant oral lesion (PMOL) for whom a biopsy is deemed necessary

Outcomes

Primary Outcomes

Number of participants for whom biopsy and CytID results both indicate presence of malignant or premalignant oral lesions

Time Frame: day 1 (at the time of oral examination)

Number of participants for whom biopsy does not indicate presence of malignant or premalignant oral lesions, but hpvID indicates presence of HPV

Time Frame: day 1 (at the time of oral examination)

Number of participants for whom biopsy indicates presence of malignant or premalignant oral lesions, but hpvID does not indicate presence of HPV

Time Frame: day 1 (at the time of oral examination)

Number of participants for whom biopsy indicates presence of malignant or premalignant oral lesions and hpvID indicates presence of HPV

Time Frame: day 1 (at the time of oral examination)

Number of participants for whom biopsy results, but not CytID results, indicate presence of malignant or premalignant oral lesions

Time Frame: day 1 (at the time of oral examination)

Number of participants for whom CytID results, but not biopsy results, indicate presence of malignant or premalignant oral lesions

Time Frame: day 1 (at the time of oral examination)

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Mark Nichols

Clinical Associate Professor

The University of Texas Health Science Center, Houston

Study Sites (1)

Loading locations...

Similar Trials

CytID Analysis of Oral Lesions | Clinical Trial